Prestige Consumer Healthcare Q1 FY27: Revenue +6.5% to $265.7M, net income -38.5% to $29.2M

Filed August 6, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 7, 2025 · ~2 min read

Key Changes

• high

  $1.045B Breathe Right acquisition closed June 12, funded by new term loan; total debt doubled to $2.0B, average borrowing cost rose 60bp to 5.1%.

  MD&A: Breathe Right acquisition; Notes: Long-Term Debt verify on EDGAR →
• high

  Gross margin compressed 490bp to 51.3% from 56.2%, driven by Pillar5 facility optimization costs and Breathe Right inventory step-up amortization.

  MD&A: Gross margin compression verify on EDGAR →
• high

  Operating income fell 27% to $52.5M despite 6.5% revenue growth; G&A surged $265.7M (52%) on acquisition costs, interest expense rose $3.7M (36%).

  MD&A: Operating income; G&A expense; Interest expense verify on EDGAR →